NeuroPace (NPCE) Capital Expenditures (2020 - 2026)
NeuroPace (NPCE) posted quarterly Capital Expenditures of $117000.0 for Q1 2026, up 216.22% year-over-year from $37000.0 in Q1 2025, and up 20.62% quarter-over-quarter from $97000.0 in Q4 2025.
NeuroPace (NPCE) Capital Expenditures (2020 - 2026) Analysis & Trends
NeuroPace's Capital Expenditures history runs 7 years deep, the most recent figure standing at $117000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures rose 216.22% year-over-year to $117000.0; the TTM figure through Mar 2026 stood at $412000.0 (up 41100.0% YoY), while the FY2025 annual figure was $332000.0, up 1647.37% from the prior year.
- Capital Expenditures for Q1 2026 stood at $117000.0, up from $97000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $439000.0 in Q2 2022, with the low at -$248000.0 in Q4 2024.
- The 5-year median for Capital Expenditures is $76000.0 (2024), against an average of $77750.0.
- Peak annual rise in Capital Expenditures reached 1011.11% in 2024, while the deepest fall reached 875.0% in 2024.
- NeuroPace's Capital Expenditures stood at $102000.0 in 2022, then plunged by 68.63% to $32000.0 in 2023, then plunged by 875.0% to -$248000.0 in 2024, then surged by 139.11% to $97000.0 in 2025, then climbed by 20.62% to $117000.0 in 2026.
- Business Quant data shows NPCE's Capital Expenditures at $117000.0 in Q1 2026, $97000.0 in Q4 2025, and $30000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.32 Bn | 196.72 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 126.69 Bn | 123.22 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 119.38 Bn | 110.16 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 74.54 Bn | 74.00 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 51.77 Bn | 47.52 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 34.82 Bn | 32.87 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 33.86 Bn | 31.76 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.32 Bn | 23.00 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.23 Bn | 22.74 Bn | 684.20 Mn | 87.50 Mn |
| 10 | NeuroPace | 483.26 Mn | 431.56 Mn | 18.91 Mn | 125,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 125,000.00 |
| Jun 30, 2026 | 125,000.00 |
| Mar 31, 2026 | 117,000.00 |
| Mar 31, 2026 | 117,000.00 |
| Dec 31, 2025 | 97,000.00 |
| Dec 31, 2025 | 97,000.00 |
| Sep 30, 2025 | 30,000.00 |
| Sep 30, 2025 | 30,000.00 |
| Jun 30, 2025 | 168,000.00 |
| Jun 30, 2025 | 168,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Dec 31, 2024 | -248,000.00 |
| Dec 31, 2024 | -248,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 112,000.00 |
| Jun 30, 2024 | 112,000.00 |
| Mar 31, 2024 | 55,000.00 |
| Mar 31, 2024 | 55,000.00 |